Search
UK MHRA Project Orbis: Accelerating Global Access to Innovative Cancer Medicines Through International Regulatory Collaboration
The global regulatory landscape for oncology medicines is increasingly moving toward collaborative review models that enable faster patient access to innovative treatments. One of the most significant initiatives in this area is Project Orbis, a multinational programme that allows concurrent submission and review of promising cancer medicines across several international regulatory authorities. The UK Medicines and Healthcare products Regulatory Agency (MHRA) guidance on Proj
Sharan Murugan
3 hours ago3 min read